Steven J. Burdick , MD
, assistant professor in the Department of Internal Medicine at the University of Texas Southwestern Medical Center
in Dallas , told Gastroenterology & Endoscopy News that this is an important study because adenocarcinoma of the esophagus is the fastest-growing cancer in the United States.And Barrett's mucosa/intestinal metaplasia is a known risk factor of adenocarcinoma , said Dr. Burdick
Although [ the study patients were ] not compared to a control population , the decrease in length of Barrett's and decrease in dysplasia would suggest a lower cancer risk after photodynamic therapy , Dr. Burdick
added.However , more insight into [ the patients' ] quality of life , reflux symptoms and dysphagia is needed to allow comparisons to traditional surgical approaches..
–Trevor W. Brown , MSc
This article is derived from the McMahon Archives.This information may be time sensitive and was archived on 7/18/2000.